Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2021


Benzinga | Feb 18, 2021 10:02AM EST

Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2021



Upgrades

* According to Ladenburg Thalmann, the prior rating for Invitae Corp (NYSE:NVTA) was changed from Neutral to Buy. For the fourth quarter, Invitae had an EPS of $0.63, compared to year-ago quarter EPS of $0.63. At the moment, the stock has a 52-week-high of $61.59 and a 52-week-low of $7.42. Invitae closed at $47.87 at the end of the last trading period.

* According to Maxim Group, the prior rating for Titan Pharmaceuticals Inc (NASDAQ:TTNP) was changed from Hold to Buy. The current stock performance of Titan Pharmaceuticals shows a 52-week-high of $4.30 and a 52-week-low of $0.09. Moreover, at the end of the last trading period, the closing price was at $3.55.

* According to Berenberg, the prior rating for Varonis Systems Inc (NASDAQ:VRNS) was changed from Hold to Buy. In the fourth quarter, Varonis Systems showed an EPS of $0.34, compared to $0.09 from the year-ago quarter. The stock has a 52-week-high of $226.00 and a 52-week-low of $48.95. At the end of the last trading period, Varonis Systems closed at $200.82.

* According to Credit Suisse, the prior rating for Mohawk Industries Inc (NYSE:MHK) was changed from Underperform to Neutral. Mohawk Industries earned $3.54 in the fourth quarter, compared to $2.25 in the year-ago quarter. At the moment, the stock has a 52-week-high of $178.19 and a 52-week-low of $56.62. Mohawk Industries closed at $168.84 at the end of the last trading period.

* For Wells Fargo & Co (NYSE:WFC), JP Morgan upgraded the previous rating of Underweight to Neutral. In the fourth quarter, Wells Fargo showed an EPS of $0.64, compared to $0.93 from the year-ago quarter. At the moment, the stock has a 52-week-high of $48.31 and a 52-week-low of $20.76. Wells Fargo closed at $36.56 at the end of the last trading period.

* Berenberg upgraded the previous rating for STMicroelectronics NV (NYSE:STM) from Sell to Hold. For the fourth quarter, STMicroelectronics had an EPS of $0.63, compared to year-ago quarter EPS of $0.43. At the moment, the stock has a 52-week-high of $43.02 and a 52-week-low of $14.67. STMicroelectronics closed at $41.73 at the end of the last trading period.

See all analyst ratings upgrades.



Downgrades

* According to Seaport Global, the prior rating for Andersons Inc (NASDAQ:ANDE) was changed from Buy to Neutral. In the fourth quarter, Andersons showed an EPS of $0.59, compared to $0.55 from the year-ago quarter. The stock has a 52-week-high of $29.29 and a 52-week-low of $10.00. At the end of the last trading period, Andersons closed at $27.44.

* For Tilray Inc (NASDAQ:TLRY), Benchmark downgraded the previous rating of Buy to Hold. Tilray earned $0.45 in the fourth quarter, compared to $0.62 in the year-ago quarter. The current stock performance of Tilray shows a 52-week-high of $67.00 and a 52-week-low of $2.43. Moreover, at the end of the last trading period, the closing price was at $31.51.

* For KAR Auction Services Inc (NYSE:KAR), Stephens & Co. downgraded the previous rating of Overweight to Equal-Weight. For the fourth quarter, KAR Auction Services had an EPS of $0.01, compared to year-ago quarter EPS of $0.19. The stock has a 52-week-high of $23.53 and a 52-week-low of $9.41. At the end of the last trading period, KAR Auction Services closed at $15.88.

* According to Baird, the prior rating for Kratos Defense & Security Solutions Inc (NASDAQ:KTOS) was changed from Outperform to Neutral. Kratos Defense & Security earned $0.14 in the third quarter, compared to $0.09 in the year-ago quarter. The current stock performance of Kratos Defense & Security shows a 52-week-high of $34.11 and a 52-week-low of $5.00. Moreover, at the end of the last trading period, the closing price was at $33.24.

* For TechnipFMC PLC (NYSE:FTI), UBS downgraded the previous rating of Buy to Neutral. For the third quarter, TechnipFMC had an EPS of $0.16, compared to year-ago quarter EPS of $0.12. At the moment, the stock has a 52-week-high of $17.59 and a 52-week-low of $4.49. TechnipFMC closed at $7.79 at the end of the last trading period.

* For Noble Midstream Partners LP (NASDAQ:NBLX), Credit Suisse downgraded the previous rating of Outperform to Neutral. Noble Midstream Partners earned $0.44 in the fourth quarter, compared to $0.65 in the year-ago quarter. At the moment, the stock has a 52-week-high of $20.60 and a 52-week-low of $1.81. Noble Midstream Partners closed at $13.97 at the end of the last trading period.

See all analyst ratings downgrades.



Initiations

* Seaport Global initiated coverage on ConnectOne Bancorp Inc (NASDAQ:CNOB) with a Buy rating. The price target for ConnectOne Bancorp is set to $27.00. In the fourth quarter, ConnectOne Bancorp showed an EPS of $0.64, compared to $0.61 from the year-ago quarter. The stock has a 52-week-high of $24.26 and a 52-week-low of $8.86. At the end of the last trading period, ConnectOne Bancorp closed at $22.71.

* Wedbush initiated coverage on Dream Finders Homes Inc (NASDAQ:DFH) with a Neutral rating. The price target for Dream Finders Homes is set to $21.00. The stock has a 52-week-high of $31.98 and a 52-week-low of $17.55. At the end of the last trading period, Dream Finders Homes closed at $26.14.

* With a Buy rating, Jefferies initiated coverage on VistaGen Therapeutics Inc (NASDAQ:VTGN). The price target seems to have been set at $6.00 for VistaGen Therapeutics. VistaGen Therapeutics earned $0.07 in the third quarter, compared to $0.15 in the year-ago quarter. At the moment, the stock has a 52-week-high of $2.94 and a 52-week-low of $0.30. VistaGen Therapeutics closed at $2.06 at the end of the last trading period.

* With a Hold rating, Stifel initiated coverage on McAfee Corp (NASDAQ:MCFE). The price target seems to have been set at $20.00 for McAfee. For the third quarter, McAfee had an EPS of $0.00, compared to year-ago quarter EPS of $0.02. At the moment, the stock has a 52-week-high of $22.14 and a 52-week-low of $14.80. McAfee closed at $19.28 at the end of the last trading period.

* With a Buy rating, Stifel initiated coverage on Cognyte Software Ltd (NASDAQ:CGNT). The price target seems to have been set at $42.00 for Cognyte Software. The stock has a 52-week-high of $33.50 and a 52-week-low of $23.75. At the end of the last trading period, Cognyte Software closed at $29.75.

* With a Buy rating, HC Wainwright & Co. initiated coverage on Liminal Biosciences Inc (NASDAQ:LMNL). The price target seems to have been set at $11.00 for Liminal Biosciences. In the third quarter, Liminal Biosciences earned $0.74. The stock has a 52-week-high of $31.45 and a 52-week-low of $3.51. At the end of the last trading period, Liminal Biosciences closed at $5.74.

* Piper Sandler initiated coverage on Infinity Pharmaceuticals Inc (NASDAQ:INFI) with an Overweight rating. The price target for Infinity Pharmaceuticals is set to $7.00. In the third quarter, Infinity Pharmaceuticals showed an EPS of $0.16, compared to $0.20 from the year-ago quarter. At the moment, the stock has a 52-week-high of $5.98 and a 52-week-low of $0.60. Infinity Pharmaceuticals closed at $3.81 at the end of the last trading period.

* With a Buy rating, Needham initiated coverage on TechTarget Inc (NASDAQ:TTGT). The price target seems to have been set at $115.00 for TechTarget. In the fourth quarter, TechTarget showed an EPS of $0.46, compared to $0.27 from the year-ago quarter. The stock has a 52-week-high of $101.12 and a 52-week-low of $16.82. At the end of the last trading period, TechTarget closed at $92.62.

* Needham initiated coverage on Rocket Pharmaceuticals Inc (NASDAQ:RCKT) with a Buy rating. The price target for Rocket Pharmaceuticals is set to $75.00. In the third quarter, Rocket Pharmaceuticals showed an EPS of $0.53, compared to $0.38 from the year-ago quarter. The stock has a 52-week-high of $67.48 and a 52-week-low of $9.01. At the end of the last trading period, Rocket Pharmaceuticals closed at $52.62.

* With a Buy rating, Needham initiated coverage on Generation Bio Co (NASDAQ:GBIO). The price target seems to have been set at $50.00 for Generation Bio. Generation Bio earned $0.46 in the third quarter, compared to $3.31 in the year-ago quarter. The stock has a 52-week-high of $55.72 and a 52-week-low of $18.80. At the end of the last trading period, Generation Bio closed at $31.79.

See all analyst ratings initiations.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC